Ignite Creation Date:
2025-12-24 @ 7:24 PM
Ignite Modification Date:
2025-12-29 @ 5:32 PM
Study NCT ID:
NCT00126503
Status:
COMPLETED
Last Update Posted:
2015-01-15
First Post:
2005-08-02
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Sorafenib Tosylate and Bevacizumab in Treating Patients With Advanced Kidney Cancer
Sponsor:
National Cancer Institute (NCI)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2005-05
Start Date Type:
None
Primary Completion Date:
2011-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2012-02
Completion Date Type:
ACTUAL
First Submit Date:
2005-08-02
First Submit QC Date:
None
Study First Post Date:
2005-08-04
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2012-11-16
Results First Submit QC Date:
None
Results First Post Date:
2013-06-28
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2015-01-06
Last Update Post Date:
2015-01-15
Last Update Post Date Type:
ESTIMATED